Eun-Seok Kim

Chief Executive Officer at DAE HWA PHARMACEUTICAL CO., LTD.

Net worth: 3 M $ as of 2024-04-29

48 year

Health Technology

Consumer Services

Profile

Eun-Seok Kim is currently the President, Co-Chief Executive Officer & Director at DAE HWA PHARM Co., Ltd.
and a Director at RedoxBio Co., Ltd.
He has a background in undergraduate and graduate studies from Sungkyunkwan University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
DAE HWA PHARM CO., LTD. 1.05%	2024-04-04	195,000 ( 1.05% )	2 M $	2024-04-29
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. 2.52%	2023-03-30	621,300 ( 2.52% )	1 M $	2020-12-30

Eun-Seok Kim active positions

Companies	Position	Start
DAE HWA PHARMACEUTICAL CO., LTD.	Chief Executive Officer	2015-03-19
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea.	Director/Board Member	-